Similar articles

• Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.

  Pujol P, Rey JM, Nirde P, Roger P, Gastaldi M, Laffargue F, Rochefort H, Maudelonde T. Pujol P, et al. Cancer Res. 1998 Dec 1;58(23):5367-73. Cancer Res. 1998. PMID: 9850067
• Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis.

  Lazennec G. Lazennec G. Cancer Lett. 2006 Jan 18;231(2):151-7. doi: 10.1016/j.canlet.2005.01.021. Cancer Lett. 2006. PMID: 16399219 Free PMC article. Review.
• FSH receptor binding inhibitor restrains follicular development and possibly attenuates carcinogenesis of ovarian cancer through down-regulating expression levels of FSHR and ERβ in normal ovarian tissues.

  Zhuandi G, Tuanjie C, Luju L, Abdiryim A, Yingying D, Haoqin L, Suocheng W, Li D. Zhuandi G, et al. Gene. 2018 Aug 20;668:174-181. doi: 10.1016/j.gene.2018.05.068. Epub 2018 May 18. Gene. 2018. PMID: 29783074
• Estrogens and epithelial ovarian cancer.

  Cunat S, Hoffmann P, Pujol P. Cunat S, et al. Gynecol Oncol. 2004 Jul;94(1):25-32. doi: 10.1016/j.ygyno.2004.03.026. Gynecol Oncol. 2004. PMID: 15262115 Review.
• Involvement of estrogen receptor beta in ovarian carcinogenesis.

  Bardin A, Hoffmann P, Boulle N, Katsaros D, Vignon F, Pujol P, Lazennec G. Bardin A, et al. Cancer Res. 2004 Aug 15;64(16):5861-9. doi: 10.1158/0008-5472.CAN-04-0552. Cancer Res. 2004. Retraction in: Cancer Res. 2005 Jun 15;65(12):5480. doi: 10.1158/0008-5472.can-correction3. PMID: 15313930 Retracted.